- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05051059
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients (QOLSarcoma)
Primary bone and soft tissue sarcomas are an exceptionally rare form of cancer, collectively accounting for only 1% of all malignancies diagnosed. Sarcomas often occur in the patients' extremities and treatment typically involves limb salvage surgery with bone and/or muscle resection. These surgeries often leave the patients with disfigurements, psychological trauma, and functional disabilities. Perhaps, the most difficult and life-altering decision that patients (and their parents) with primary bone sarcomas about the knee joint have to make, involves choosing the type of surgical procedure that will provide them with the outcome that meets their functional as well as aesthetic expectations.
In literature, the quality of life for patients with osteosarcoma around the knee joint after three different surgical procedures, that is, amputation, endoprosthetic reconstruction and rotationplasty was evaluated. There was found that patients treated with rotationplasty showed significantly higher functional scores compared to the two other groups of patients. Also, researchers investigated the long-term quality of life after bone sarcoma surgery around the knee joint and found that, despite the functional disability, survivors were busy with work, study, relationships, and sometimes they have founded a family.
Most published reports in the literature on assessment of gait in the lower-extremity sarcoma survivors were focused on bone sarcoma patients after wide resection and endoprosthetic reconstruction. To the knowledge of the investigator, there has been no published studies on gait analysis after resection of soft tissue sarcomas (STS) of the lower extremity. The rare and heterogeneous aspects of STS and the paucity of knowledge of movement strategies in these patients hinder the development of effective rehabilitation protocols for recovering movement after resection of STS in the lower limb.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary bone and soft tissue sarcomas are an exceptionally rare form of cancer, collectively accounting for only 1% of all malignancies diagnosed. There have been dramatic improvements in the survival rate of sarcoma patients in the past 40 years owing to increasing effectiveness of chemotherapy. This, along with developments in imaging techniques, have led to earlier diagnosis and more accurate preoperative staging. It is estimated that there are nearly 50,000 survivors of bone and soft tissue sarcomas in the United States. 70% of those are younger than the age of 50 years. Whilst traditional treatment for bone tumors used to be amputation, advances in surgical techniques have made limb-salvage procedures a valid alternative method of treatment in 80-85% of patients with primary bone sarcomas.
Sarcomas often occur in the patients' extremities and treatment typically involves limb salvage surgery with bone and/or muscle resection. These surgeries often leave the patients with disfigurements, psychological trauma, and functional disabilities. Perhaps, the most difficult and life-altering decision that patients (and their parents) with primary bone sarcomas about the knee joint have to make, involves choosing the type of surgical procedure that will provide them with the outcome that meets their functional as well as aesthetic expectations. In literature, the quality of life for patients with osteosarcoma around the knee joint after three different surgical procedures, that is, amputation, endoprosthetic reconstruction and rotationplasty was evaluated. There was found that patients treated with rotationplasty showed significantly higher functional scores compared to the two other groups of patients. Also, researchers investigated the long-term quality of life after bone sarcoma surgery around the knee joint and found that, despite the functional disability, survivors were busy with work, study, relationships, and sometimes they have founded a family.
There are few reports available in the literature on the quality of life in sarcoma survivors. It was found that elderly patients, retired patients, and those who live alone need more intensive psychological care. Female patients were found to cope poorly with their disease compared to male gender. It was also found that the physical status greatly influences the overall outcome and quality of life in this group of patients. This stresses the importance of enrolment in tailored rehabilitation programs.
Most published reports in the literature on assessment of gait in the lower-extremity sarcoma survivors were focused on bone sarcoma patients after wide resection and endoprosthetic reconstruction. In literature, the gait pattern after endoprosthetic replacement around the knee joint was studied and found that, despite decreased walking velocity, stride length, and stance phase of the operated limb, these patients still have a symmetrical gait. Also in another report, an electromyographic assessment of gait after bone sarcoma surgery about the knee showed prolonged activation of rectus femoris and hamstring muscles in the affected limb compared to a control group. Other researchers found that limb-salvage patients often adopt a "stiff-legged" gait pattern. These findings are of utmost importance for the development of efficient rehabilitation programs for these patients.
To the knowledge of the investigator, there has been no published studies on gait analysis after resection of soft tissue sarcomas (STS) of the lower extremity. The rare and heterogeneous aspects of STS and the paucity of knowledge of movement strategies in these patients hinder the development of effective rehabilitation protocols for recovering movement after resection of STS in the lower limb. Researchers investigated the knee extension strength and postoperative functional outcome after quadriceps resection for soft tissue sarcoma of the thigh. They found that knee extension strength decreased when the number of resected quadriceps increased and this was associated with lower functional scores. They concluded that good functional results can be expected if at least two quadriceps muscles are preserved. However, no detailed assessment of gait in this group of patients has been published.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hazem Wafa
- Phone Number: +32 16 33 88 73
- Email: hazem.wafa@uzleuven.be
Study Contact Backup
- Name: Moke Lieven
- Phone Number: +32 16 34 08 84
- Email: lieven.moke@uzleuven.be
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- Recruiting
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who underwent limb salvage surgery for bone or soft tissue sarcoma of the lower extremity at UZ Leuven
- 18 to 95 years old
- Patients should be at least one year post surgery
- Informed consent has obtained
Exclusion Criteria:
- Patients who received major prior surgery of the lower limbs or with any pathology, injury or disorder known to affect the locomotor system
- Skeletally immature individuals
- No informed consent has obtained
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Soft tissue sarcoma of the thigh
Patients who underwent surgical resection of a deep intramuscular soft tissue sarcoma of the thigh
|
3D-motion analysis and strength assessment
Quality of Life Questionnaire C-30 (QLQ-C30), Impact on Participation and Autonomy Questionnaire (IPAQ) and Musculoskeletal Tumor Society Score (MSTS)
|
|
No Intervention: Control group
A group of healthy age-matched individuals will be identified out of an available gait lab database to compare the gait pattern with tha of the patient group
|
|
|
Other: Bone or soft tissue sarcoma of the lower extremity
Patients who underwent surgical resection of a bone or soft tissue sarcoma of the lower extremity
|
Quality of Life Questionnaire C-30 (QLQ-C30), Impact on Participation and Autonomy Questionnaire (IPAQ) and Musculoskeletal Tumor Society Score (MSTS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Musculoskeletal Tumor Society Score (MSTS)
Time Frame: Within a period of 1 year
|
To determine the physical and mental health for patients with extremity sarcoma
|
Within a period of 1 year
|
|
Quality of Life Questionnaire C-30 (QLQ-C30)
Time Frame: Within a period of 1 year
|
To measure cancer patients' physical, psychological and social functions
|
Within a period of 1 year
|
|
Participation and Autonomy Questionnaire Questionnaire (IPAQ)
Time Frame: Within a period of 1 year
|
To measure health-related physical activity
|
Within a period of 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hazem Wafa, Universitaire Ziekenhuizen KU Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Bone Diseases
- Musculoskeletal Diseases
- Neoplasms by Site
- Neoplasms
- Neoplasms by Histologic Type
- Neoplasms, Connective and Soft Tissue
- Sarcoma
- Bone Neoplasms
- Investigative Techniques
- Therapeutics
- Public Health
- Environment and Public Health
- Health Status
- Demography
- Epidemiologic Measurements
- Behavior Control
- Immobilization
- Quality of Life
- Restraint, Physical
Other Study ID Numbers
- S63146
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Soft Tissue Sarcoma
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Stage IIA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma
-
National Institutes of Health Clinical Center (CC)CompletedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IVA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma | Stage IVB Adult Soft Tissue Sarcoma
-
ImmunityBio, Inc.CompletedUnresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue SarcomaUnited States, Australia, Russian Federation, Hungary, India, Romania, Ukraine
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part Sarcoma | Advanced Soft Tissue Sarcoma | Advanced Alveolar Soft Part Sarcoma | Refractory Alveolar Soft Part SarcomaUnited States
-
University of WashingtonAadi Bioscience, Inc.TerminatedAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue SarcomaUnited States
-
Centre Oscar LambretCentre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE... and other collaboratorsNot yet recruitingSoft Tissue Sarcoma Adult | Soft Tissue Sarcoma of the Limb | Soft Tissue Sarcoma (Excluding GIST) | Soft Tissue Sarcoma of the Trunk and ExtremitiesFrance
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue SarcomaUnited States
-
Adcendo ApSRecruitingUnresectable Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States, France, United Kingdom, Belgium, Germany
-
UNICANCERRecruitingAdvanced Soft-tissue Sarcoma | Metastatic Soft-tissue SarcomaFrance
-
University of Colorado, DenverAgenus Inc.Active, not recruitingAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
Clinical Trials on Functional outcome
-
Izmir Katip Celebi UniversityUnknown
-
NovaVision, Inc.SuspendedHemianopsia, HomonymousUnited States
-
Beijing Neurosurgical InstituteRecruitingCerebral Hemorrhage | Artificial Intelligence | PrognosisChina
-
University Hospital, Basel, SwitzerlandCompleted
-
Torbay and South Devon NHS Foundation TrustTerminatedProximal Humeral FractureUnited Kingdom
-
University Hospital, Basel, SwitzerlandCompletedInjury of the Anterior Cruciate Ligament (ACL)Switzerland
-
VA Office of Research and DevelopmentRecruitingAmputation, Lower LimbUnited States
-
Oslo University HospitalHaukeland University Hospital; St. Olavs Hospital; University Hospital of Northern...RecruitingLeiomyosarcoma | Soft Tissue Sarcoma Adult | Liposarcoma | Pleomorphic Rhabdomyosarcoma | Soft Tissue Sarcoma (Excluding GIST) | Soft Tissue Sarcoma of the Trunk and Extremities | Undifferentiated Pleomorphic Sarcoma (UPS) | Myxofibrosarcoma (MFS) | Synovial SarcomasNorway
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
London Health Sciences Centre Research Institute...Active, not recruiting